OncoZenge: SEK3.3m directed issue to specialist investors
Redeye comments on yesterday’s announcement that OncoZenge has carried out a directed share issue of SEK3.3m to Life Science Invest Fund (LSIF)...
87 Views
OncoZenge: Guarantor compensation and bridge loan set-off
Redeye briefly comments on yesterday’s announcement that OncoZenge has resolved on two directed share issues, one to Vator Securities as...
83 Views
OncoZenge: Rights issue concludes at ~92% subscription
Redeye comments on yesterday’s announcement that OncoZenge’s rights issue has concluded, with combined subscription of approximately 92% and gross...
82 Views
OncoZenge: New patent application targets dental and oral pain
Redeye comments on today's announcement that OncoZenge has filed a new medical use patent application with the Swedish Intellectual Property...
88 Views
OncoZenge (Q2 Review): En route to market – Pivotal study up and running
Redeye provides a research update following the Q2 report recently published by OncoZenge. The report was largely in line with our expectations,...
91 Views